Kerastem is focused on the development of product solutions for women and men with early hair loss. The company’s core technology focuses on the emerging relationship between adipose (fat) tissue and hair, highlighting the increasingly important role that adipose plays in driving the hair growth cycle.*
Kerastem is a Bimini Technologies’ company. Bimini is a private holding company focused on the aesthetic, cash-pay marketplace. The company seeks market approved or high-potential performing assets that complement or expand the existing product portfolio.
Today, the Bimini group of companies includes Puregraft and Kerastem. Puregraft is the world’s market leader in the commercialization of innovative fat transfer tools. Today, Puregraft’s products are distributed in over 60 countries worldwide.
Kerastem is a wholly owned subsidiary of Bimini Technologies. In the United States, Kerastem has a focused US FDA Clinical Trial Strategy to enable driving hair growth therapies to market. Kerastem’s solution for male and female pattern baldness is currently in a phase II clinical trial. Kerastem is in parallel actively engaged in market development activities in Europe and Japan.
Brad Conlan Chief Executive Officer
Mr. Conlan is the co-founder of Bimini Technologies and has served as ...
Mr. Conlan is the co-founder of Bimini Technologies and has served as CEO since 2013. Mr. Conlan has worked in the regenerative medicine space for over 15 years, most recently with Cytori Therapeutics (NASDAQ: CYTX) where he served as the Company’s Director of Global Marketing as well as head of the Regenerative Medicine Business Unit. During his time at Cytori, Mr. Conlan was directly responsible for the research and development of the Celution Cell Therapy platform and Puregraft Fat Transfer products and managed cross functional teams that drove the products from concept to commercialization. Mr. Conlan received a B.S in Biomedical and Industrial Engineering from University of Iowa and a M.S. in Biomedical Engineering from the University of Southern California.
Eric Daniels MD, MBA Chief Medical Officer
Dr. Eric Daniels currently serves as the Chief Medical Officer of ...
Eric Daniels MD, MBA
Dr. Eric Daniels currently serves as the Chief Medical Officer of Bimini Technologies. Prior to joining Bimini, Dr. Daniels served as the Vice President, Marketing & Sales for Tensys Medical. Tensys is a private equity backed leader in the field of non-invasive hemodynamic monitoring. Prior to Tensys, Dr. Daniels spent 11 years at Cytori Therapeutics, a leading cell-therapy company focused exclusively on adipose tissue. Dr. Daniels served in a variety of roles at Cytori, most recently as the Managing Director-EMEA. Dr. Daniels has published a number of papers on the role of adipose derived regenerative cells. Dr. Daniels holds a Masters of Business Administration from the Anderson School of Management at the University of California, Los Angeles. Dr. Daniels received his Doctor of Medicine degree from the University of California, Los Angeles School of Medicine and his undergraduate degree in Molecular Biology from the University of California, Berkeley.